Gastrointestinal Cancer News and Research

RSS

Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract, including the esophagus, stomach, liver, biliary system, pancreas, bowels, and anus.

Exercise helps gastrointestinal cancer patients cope better with side effects of chemotherapy

Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.

10 Mar 2017

Immune-stimulating chemical found in tumors may help stop cancer growth

A chemical found in tumors may help stop tumor growth, according to a new study.

2 Mar 2017

Study shows evidence that intestinal microorganisms can serve as link between diet and colorectal cancer

A new study provides some of the strongest evidence to date that microorganisms living in the large intestine can serve as a link between diet and certain types of colorectal cancer, the lead authors at Dana-Farber Cancer Institute and Massachusetts General Hospital report.

28 Jan 2017

Pancreatic cancer to become third leading cause of death in the EU in 2017

The number of deaths from pancreatic cancer will overtake breast cancer mortality rates in the EU in 2017, a study has found.

7 Nov 2016

Cancer risk screening for hereditary mutations: an interview with Ted Snelgrove

Great question – the answer is actually unknown. Every month, there are publications that report on new cancer-related genes, so it's an area of great knowledge growth at the moment.

26 Jul 2016

TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

Merck, a leading science and technology company, will present data at the ESMO 18th World Congress on Gastrointestinal Cancer from the pivotal Phase III TAILOR study in patients from China, the first prospective trial to evaluate an anti-EGFR antibody in the first-line therapy of patients with RAS wild-type metastatic colorectal cancer (mCRC).

4 Jul 2016

Chemoradiotherapy and post-operative chemotherapy provide similar outcomes in gastric cancer patients

Post-operative treatment intensification with chemoradiotherapy does not achieve better outcomes when compared to post-operative chemotherapy in patients with gastric cancer who have already undergone pre-operative chemotherapy, according to phase III data presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.

4 Jul 2016

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data presented at the European Society for Medical Oncology's 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.

4 Jul 2016

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.

30 Jun 2016

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

NETTER-1 study, showing clinically meaningful and significant results for Lutathera (77Lu-DOTA0-Tyr3-Octreotate) in patients with metastatic midgut neuroendocrine tumors (NETs). The data will be presented Monday, June 6, during the American Society of Clinical Oncology Annual Meeting in Chicago.

6 Jun 2016

Personlized exercise pattern may help reduce neuropathic symptoms of chemotherapy

Researchers at the University of Rochester Wilmot Cancer Institute discovered something simple and inexpensive to reduce neuropathy in hands and feet due to chemotherapy--exercise.

6 Jun 2016

Nutrition, safety tips for grilling season

Cooking meat, including beef, pork, fish, or poultry, with high-temperature methods such as pan frying or grilling directly over an open flame can increase exposure to chemicals that can cause changes in DNA that may increase the risk of cancer, according to the National Cancer Institute.

25 May 2016

Regular use of aspirin significantly reduces overall cancer risk

An analysis of data from two major, long-term epidemiologic studies finds that the regular use of aspirin significantly reduces the overall risk of cancer, a reduction that primarily reflects a lower risk of colorectal cancer and other tumors of the gastrointestinal tract.

4 Mar 2016

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

With cancer survival rates in the UK persistently trailing comparable European countries, it’s time to admit to a national problem – and do something about it, says a leading expert at the Primary Care Society for Gastroenterology.

6 Nov 2015

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Gastric cancer, otherwise known as stomach cancer, does not respond well to existing treatments and it is currently the third leading cause of cancer death in the world (after lung and liver cancer). Researchers have discovered that certain drugs, currently used to treat breast, ovarian and pancreatic cancers, could also be used to treat certain gastric cancers with a particular pattern of mutations (genomic molecular fingerprint).

29 Oct 2015

Baylor study identifies biomarker that could help determine treatment strategies for colorectal cancer patients

Researchers at Baylor Research Institute have identified a small RNA molecule that appears to enable certain colorectal cancers to become especially aggressive, resistant to treatment and likely to migrate and invade normal tissue.

19 Oct 2015

Study may lead to new insights on use of aspirin in GI cancer

Aspirin improves survival in patients with tumours situated throughout the gastrointestinal (GI) tract, results from a large study in The Netherlands show. This is the first time that survival data from patients with tumours in different GI locations have been analysed at the same time; previously, only one type of cancer, usually colorectal, was studied.

28 Sep 2015

Gastrointestinal Cancer News and Research

Further Reading

Exercise helps gastrointestinal cancer patients cope better with side effects of chemotherapy

Immune-stimulating chemical found in tumors may help stop cancer growth

Study shows evidence that intestinal microorganisms can serve as link between diet and colorectal cancer

Pancreatic cancer to become third leading cause of death in the EU in 2017

Cancer risk screening for hereditary mutations: an interview with Ted Snelgrove

TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

Chemoradiotherapy and post-operative chemotherapy provide similar outcomes in gastric cancer patients

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Personlized exercise pattern may help reduce neuropathic symptoms of chemotherapy

Nutrition, safety tips for grilling season

Regular use of aspirin significantly reduces overall cancer risk

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Baylor study identifies biomarker that could help determine treatment strategies for colorectal cancer patients

Study may lead to new insights on use of aspirin in GI cancer

Using integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya Das

Three medical oncologists to receive ESMO's acclaimed awards

LINE-1 jumping gene unusually active in gastrointestinal cancer

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News